Ferring Pharmaceuticals Inc. v. Par Pharmaceutical, Inc.

U.S. Court of Appeals for the Federal Circuit

Ferring Pharmaceuticals Inc. v. Par Pharmaceutical, Inc.

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

FERRING PHARMACEUTICALS INC., FERRING INTERNATIONAL CENTER SA, Plaintiffs-Appellees

v.

PAR PHARMACEUTICAL, INC., Defendant-Appellant ______________________

2017-2399 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:15-cv-00173-RGA, Judge Richard G. Andrews. ______________________

JUDGMENT ______________________

MARY W. BOURKE, Womble Bond Dickinson (US) LLP, Wilmington, DE, argued for plaintiffs-appellees. Also represented by DANIEL M. ATTAWAY, DANA KATHRYN SEVERANCE; JOHN W. COX, Atlanta, GA.

RICHARD J. BERMAN, Arent Fox, LLP, Washington, DC, argued for defendant-appellant. Also represented by TANIEL ERMANO ANDERSON, JANINE A. CARLAN. ______________________ THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (REYNA, SCHALL, and STOLL, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

June 8, 2018 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Reference

Status
Unpublished